Dine Brands Global (NYSE: DIN) has recently received a number of price target changes and ratings updates: 3/10/2022 – Dine Brands Global had its price target raised by analysts at Truist Financial Co. from $112.00 to $114.00. They now have a “buy” rating on the stock. 3/8/2022 – Dine Brands Global was downgraded by analysts […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) has earned a consensus recommendation of “Hold” from the ten analysts that are presently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating on the company. The average […]
Shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) have earned a consensus recommendation of “Buy” from the fifteen analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and twelve have given a buy recommendation to the company. […]
Bogart Wealth LLC boosted its stake in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 40.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,523 shares of the health services provider’s stock after purchasing an additional 6,248 shares during the […]
Shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) have been assigned a consensus recommendation of “Buy” from the fifteen ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and twelve have given a buy rating to the company. […]